WO2001048209A3 - Genes identified as required for proliferation of e. coli - Google Patents
Genes identified as required for proliferation of e. coli Download PDFInfo
- Publication number
- WO2001048209A3 WO2001048209A3 PCT/US2000/034419 US0034419W WO0148209A3 WO 2001048209 A3 WO2001048209 A3 WO 2001048209A3 US 0034419 W US0034419 W US 0034419W WO 0148209 A3 WO0148209 A3 WO 0148209A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- coli
- proliferation
- screen
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001548722A JP2003518386A (en) | 1999-12-23 | 2000-12-19 | Genes identified as required for the growth of Escherichia coli |
CA002395335A CA2395335A1 (en) | 1999-12-23 | 2000-12-19 | Genes identified as required for proliferation of e. coli |
AU22774/01A AU2277401A (en) | 1999-12-23 | 2000-12-19 | Genes identified as required for proliferation of e. coli |
EP00986553A EP1244789A2 (en) | 1999-12-23 | 2000-12-19 | Genes identified as required for proliferation of e. coli |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17300599P | 1999-12-23 | 1999-12-23 | |
US60/173,005 | 1999-12-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001048209A2 WO2001048209A2 (en) | 2001-07-05 |
WO2001048209A3 true WO2001048209A3 (en) | 2002-05-02 |
WO2001048209B1 WO2001048209B1 (en) | 2002-06-06 |
Family
ID=22630109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/034419 WO2001048209A2 (en) | 1999-12-23 | 2000-12-19 | Genes identified as required for proliferation of e. coli |
Country Status (7)
Country | Link |
---|---|
US (1) | US20020022718A1 (en) |
EP (1) | EP1244789A2 (en) |
JP (1) | JP2003518386A (en) |
KR (1) | KR20030003221A (en) |
AU (1) | AU2277401A (en) |
CA (1) | CA2395335A1 (en) |
WO (1) | WO2001048209A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2041901A (en) * | 1999-11-09 | 2001-06-06 | Elitra Pharmaceuticals, Inc. | Genes essential for microbial proliferation and antisense thereto |
JP2005532828A (en) * | 2002-07-17 | 2005-11-04 | メルク エンド カムパニー インコーポレーテッド | Methods for identifying cell growth inhibitors |
US20050026189A1 (en) * | 2003-05-29 | 2005-02-03 | Liangsu Wang | Microbial operons |
GB0312972D0 (en) * | 2003-06-05 | 2003-07-09 | Norwegian Radium Hospital Res | Screen for novel protein inhibitors |
US7455840B2 (en) * | 2003-11-19 | 2008-11-25 | The Scripps Research Institute | Compositions and methods to reduce mutagenesis |
CN101243177B (en) * | 2004-01-30 | 2012-12-05 | 味之素株式会社 | L-amino acid-producing microorganism and method for producing L-amino acid |
WO2006108075A2 (en) * | 2005-04-05 | 2006-10-12 | The Scripps Research Institute | Compositions and methods for enhancing drug sensitivity and treating drug resistant infections an diseases |
WO2008073444A2 (en) * | 2006-12-12 | 2008-06-19 | The Johns Hopkins University | Phou (perf), a persistence switch involved in persister formation as a drug target for persister bacteria |
CN101715490B (en) * | 2007-04-06 | 2014-02-05 | 协和发酵生化株式会社 | Method for production of glutathione or gamma-glutamylcysteine |
JP2010154846A (en) * | 2008-12-01 | 2010-07-15 | Sony Corp | Mutant gluconate dehydrogenase |
US20140259212A1 (en) * | 2009-11-18 | 2014-09-11 | Basf Plant Science Company Gmbh | Process for the Production of Fine Chemicals |
WO2012090789A1 (en) * | 2010-12-28 | 2012-07-05 | 国立大学法人広島大学 | Polypeptide for distinguishing silicon oxide from silicon nitride, and use thereof |
ITNA20120046A1 (en) * | 2012-08-02 | 2014-02-03 | No Self S R L | USE OF NUCLEIC ACIDS OF PARASITIC BIOLOGICAL SYSTEMS, PATOGENES AND WEATHER FOR THE INHIBITION AND / OR CONTROL OF THE SAME SYSTEMS |
US9416395B2 (en) * | 2013-03-15 | 2016-08-16 | City Of Hope | Methods, compositions, and kits for detection of aspergillosis |
US10227661B2 (en) * | 2014-11-21 | 2019-03-12 | GeneWeave Biosciences, Inc. | Sequence-specific detection and phenotype determination |
KR102124257B1 (en) * | 2018-10-19 | 2020-06-26 | 대한민국(관리부서 질병관리본부장) | Burkholderia pseudomallei diagnostic detection kit using rapid immunochromatography, its specific antibody and antibody-producing cell lines |
US20220127624A1 (en) * | 2019-02-05 | 2022-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Inducible Ammonia Production from a Symbiotic Diazotroph, Methods of Creation and Uses Thereof |
NL2022581B1 (en) * | 2019-02-14 | 2020-08-27 | Koppert Bv | Composition comprising a mixture of dna molecules, uses thereof as biological inhibitor and method for production |
US11866728B2 (en) | 2022-01-21 | 2024-01-09 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
WO2023192326A2 (en) * | 2022-03-29 | 2023-10-05 | Rutgers, The State University Of New Jersey | Attenuated maturation-defective chlamydia vaccines |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998021366A1 (en) * | 1996-11-13 | 1998-05-22 | Qbi Enterprises, Ltd. | Gene identification method |
WO1999002673A2 (en) * | 1997-07-10 | 1999-01-21 | Genesense Technologies, Inc. | Antisense oligonucleotide sequences as inhibitors of microorganisms |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0215942B1 (en) * | 1985-03-15 | 1995-07-12 | Antivirals Inc. | Polynucleotide assay reagent and method |
US5405775A (en) * | 1989-02-24 | 1995-04-11 | The University Of Medicine And Dentistry Of New Jersey | Retrons coding for hybrid DNA/RNA molecules |
US5082787A (en) * | 1989-12-22 | 1992-01-21 | Texaco Inc. | Method of performing hydrous pyrolysis for studying the kinetic parameters of hydrocarbons generated from source material |
US5639603A (en) * | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
WO1994026933A1 (en) * | 1993-05-13 | 1994-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Genetic footprinting: insertional mutagenesis and genetic selection |
US5807522A (en) * | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5463564A (en) * | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
GB9518395D0 (en) * | 1995-09-08 | 1995-11-08 | Therexsys Ltd | Plasmid stabilization |
CA2258547A1 (en) * | 1996-06-17 | 1997-12-24 | Microcide Pharmaceuticals, Inc. | Screening methods using microbial strain pools |
US6107071A (en) * | 1996-09-24 | 2000-08-22 | Smithkline Beecham Corporation | Histidinol dehydrogenase |
US6139817A (en) * | 1996-10-15 | 2000-10-31 | Smithkline Beecham Corporation | Method for determining gene essentiality in a pathogen |
US6171838B1 (en) * | 1997-08-13 | 2001-01-09 | Smithkline Beecham Corporation | ratB |
US20020115217A1 (en) * | 1997-10-02 | 2002-08-22 | Smithkline Beecham Corporation | Whole cell assay |
-
2000
- 2000-12-19 KR KR1020027008404A patent/KR20030003221A/en not_active Application Discontinuation
- 2000-12-19 JP JP2001548722A patent/JP2003518386A/en active Pending
- 2000-12-19 WO PCT/US2000/034419 patent/WO2001048209A2/en not_active Application Discontinuation
- 2000-12-19 CA CA002395335A patent/CA2395335A1/en not_active Abandoned
- 2000-12-19 AU AU22774/01A patent/AU2277401A/en not_active Abandoned
- 2000-12-19 US US09/741,669 patent/US20020022718A1/en not_active Abandoned
- 2000-12-19 EP EP00986553A patent/EP1244789A2/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998021366A1 (en) * | 1996-11-13 | 1998-05-22 | Qbi Enterprises, Ltd. | Gene identification method |
WO1999002673A2 (en) * | 1997-07-10 | 1999-01-21 | Genesense Technologies, Inc. | Antisense oligonucleotide sequences as inhibitors of microorganisms |
Non-Patent Citations (16)
Title |
---|
AUSTIN A E ET AL: "Genetic analysis of lipopolysaccharide core biosynthesis by Escherichia coli k12 insertion mutagenesis of the RFA locus", JOURNAL OF BACTERIOLOGY,WASHINGTON, DC,US, vol. 172, no. 9, September 1990 (1990-09-01), pages 5312 - 5325, XP000926028, ISSN: 0021-9193 * |
BLATTNER ET AL.: "THE COMPLETE GENOME SEQUENCE OF ESCHERICHIA COLI K-12", SCIENCE, vol. 277, 5 September 1997 (1997-09-05), pages 1453 - 1462, XP002923023 * |
DATABASE EM_PRO [online] EMBL; 19 May 1993 (1993-05-19), BURLAND ET AL.: "E. coli; the region from 81.5 to 84.5 minutes", XP002181130, retrieved from EBI accession no. ECUW82 Database accession no. L10328 * |
DATABASE EM_PRO [online] EMBL; 29 January 1997 (1997-01-29), BLATTNER ET AL.: "Escherichia coli K12 MG1655 section 298 of 400 of the complete genome", XP002181129, retrieved from EBI accession no. ECAE408 Database accession no. AE000408 * |
DATABASE EM_PRO [online] EMBL; 29 January 1997 (1997-01-29), BLATTNER ET AL.: "Escherichia coli K12 MG1655 section 337 of 400 of the complete genome", XP002181127, retrieved from EBI accession no. ECAE447 Database accession no. AE000447 * |
DATABASE EM_PRO [online] EMBL; 30 December 1994 (1994-12-30), PLUNKETT, G: "Escherichia coli K-12 chromosomal region from 67.4 to 76.0 minutes", XP002181132, retrieved from EBI accession no. ECUW67 Database accession no. U18997 * |
DATABASE EM_PRO [online] embl; 7 November 1985 (1985-11-07), CERETTI ET AL.: "Escherichia coli spc ribosomal protein operon", XP002181131, retrieved from EBI accession no. ECSPC Database accession no. X01563 * |
DATABASE SWALL [online] 1 May 1992 (1992-05-01), BURLAND ET AL.: "60 kDa inner-membrane protein", XP002181128, retrieved from EBI accession no. 60IM_ECOLI Database accession no. P25714 * |
GENE, vol. 38, 1985, pages 85 - 93, XP000915093 * |
GENOMICS, vol. 16, 1993, pages 551 - 561, XP000615272 * |
LEE N G ET AL: "Molecular cloning and characterization of the nontypable Haemophilus influenzae-2019 rfaE gene required for lipopolysaccharide biosynthesis", INFECTION AND IMMUNITY,AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON,US, vol. 63, no. 3, 1995, pages 818 - 824, XP000953326, ISSN: 0019-9567 * |
NUCLEIC ACIDS RESEARCH, vol. 11, no. 9, 1983, pages 2599 - 2616 * |
POST L E ET AL: "NUCLEOTIDE SEQUENCE OF THE RIBOSOMAL PROTEIN GENE CLUSTER ADJACENT TO THE GENE FOR RNA POLYMERASE SUBUNIT BETA IN ESCHERICHIA COLI", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA,US,NEW YORK, NY, vol. 76, no. 4, 1 April 1979 (1979-04-01), pages 1697 - 1701, XP000574791 * |
THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 46, 13 November 1998 (1998-11-13), pages 30415 - 30418 * |
VALVANO M A ET AL: "The rfaE gene from Escherichia coli encodes a bifunctional protein involved in biosynthesis of the lipopolysaccharide core precursor ADP-L-glycero-D-manno-heptose", JOURNAL OF BACTERIOLOGY,WASHINGTON, DC,US, vol. 182, no. 2, January 2000 (2000-01-01), pages 488 - 497, XP000926030, ISSN: 0021-9193 * |
VAN HEESWIJK W C ET AL: "The genes of the glutamine synthetase adenylylation cascade are not regulated by nitrogen in Escherichia coli", MOLECULAR MICROBIOLOGY,BLACKWELL SCIENTIFIC, OXFORD,GB, vol. 9, no. 3, 1993, pages 443 - 457, XP000926027, ISSN: 0950-382X * |
Also Published As
Publication number | Publication date |
---|---|
EP1244789A2 (en) | 2002-10-02 |
WO2001048209B1 (en) | 2002-06-06 |
AU2277401A (en) | 2001-07-09 |
KR20030003221A (en) | 2003-01-09 |
CA2395335A1 (en) | 2001-07-05 |
JP2003518386A (en) | 2003-06-10 |
WO2001048209A2 (en) | 2001-07-05 |
US20020022718A1 (en) | 2002-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001048209A3 (en) | Genes identified as required for proliferation of e. coli | |
WO2000044906A3 (en) | GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) | |
WO2001070955A8 (en) | Identification of essential genes in prokaryotes | |
WO2000044928A3 (en) | Materials and methods for the purification of polyelectrolytes | |
WO2002008285A3 (en) | Il-17 molecules and uses thereof | |
WO2003020932A1 (en) | Novel secretory proteins and dna thereof | |
WO2002101045A3 (en) | Vanilloid receptor-related nucleic acids and polypeptides | |
WO2002008277A3 (en) | Nucleic acids, vectors, host cells, polypeptides, and uses thereof | |
WO2001034810A3 (en) | Genes essential for microbial proliferation | |
WO2002008257A3 (en) | Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
PL374550A1 (en) | Il-17 like molecules and uses thereof | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
EP1178052A3 (en) | Genes identified as required for proliferation in Escherichia coli | |
WO2001092496A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO2002040683A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO2002022795A3 (en) | Isolated human kinase proteins, nucleic acid molecules and uses thereof | |
WO2001088148A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO2000046391A3 (en) | Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof | |
WO2001081413A3 (en) | Isolated human transporter proteins, nucleic acids and uses thereof | |
WO2002068617A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO2001081412A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof | |
WO2002046406A3 (en) | Human transporter proteins, nucleic acid molecules encoding them,and uses thereof | |
WO2002072765A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002018554A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: B1 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: B1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 519458 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2395335 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 548722 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 22774/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027008404 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000986553 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000986553 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027008404 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000986553 Country of ref document: EP |